Add Company
Join Now

Clinical Biosafety Services Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Clinical Biosafety Services's estimated annual revenue is currently $10.1M per year.(i)
  • Clinical Biosafety Services's estimated revenue per employee is $155,000

Employee Data

  • Clinical Biosafety Services has 65 Employees.(i)
  • Clinical Biosafety Services grew their employee count by -2% last year.

Clinical Biosafety Services's People

NameTitleEmail/Phone
1
Principal Partner & Chief Gene Therapy Biosafety OfficerReveal Email/Phone
2
Associate Partner and Gene Therapy Biosaftey OfficerReveal Email/Phone
3
Associate Partner and Gene Therapy Biosafety OfficerReveal Email/Phone
4
Associate Partner and Gene Therapy Biosafety OfficerReveal Email/Phone
5
Senior AP & HGT Biosafety Officer, Quality Training SpecialistReveal Email/Phone
6
Associate Partner and Gene Therapy Biosafety OfficerReveal Email/Phone
7
Biosafety ConsultantReveal Email/Phone
8
Associate Partner, IBC Services at Clinical Biosafety ServicesReveal Email/Phone
9
Recruiting and Business Services SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$79.1M5106%N/AN/A
#2
$1.1M717%N/AN/A
#3
$4.2M27-32%N/AN/A
#4
$2M1330%N/AN/A
#5
$4.3M284%N/AN/A
#6
$0.9M60%N/AN/A
#7
$5M323%N/AN/A
#8
$3.7M244%N/AN/A
#9
$0.3M40%N/AN/A
#10
$6M3950%N/AN/A
Add Company

What Is Clinical Biosafety Services?

Gene Therapy. Accelerated. Clinical Biosafety Services provides Institutional Biosafety Committee (IBC) Review and Biosafety Consulting Services. Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor. Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine, and our service is to bring the trial to enrollment fruition, quickly and compliantly.

keywords:N/A

N/A

Total Funding

65

Number of Employees

$10.1M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$75M675%N/A
#2
$18.3M706%N/A
#3
$19.6M7512%N/A
#4
$19.1M9331%N/A
#5
$18M1030%N/A